🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareFDA compounding enforcement update — June 2026 guidance document Page 11

FDA compounding enforcement update — June 2026 guidance document

RegAffairsDC Mon, Feb 26, 2024 at 4:00 PM 336 replies 53,782 viewsPage 11 of 20
DoseLogDan
Member
201
567
Feb 2025
Montana
Mar 13, 2024 at 8:07 PM#51
Dr.NutriCornell said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

This matches mine closely enough to be worth saying so out loud.

42 17newstart_MO, mia_MS2, LeilaHI and 39 others
Reply Quote Save Share Report
quinn_sf
Member
489
2,123
Jun 2024
San Francisco, CA
Mar 14, 2024 at 5:30 AM#52
Dr.NutriCornell said:
Most of what circulates confidently in this community traces back to one summary of one study, and the qualifier was dropped somewhere in the third…

Adding the part of the answer the thread has not reached. Order of operations matters more than any single choice here: establish a baseline, change one thing, wait long enough for it to express itself, then measure again under the same conditions.

41 16Dr.PathRoch, mona_PHX, andrew_nyc and 38 others
Reply Quote Save Share Report
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Mar 14, 2024 at 2:53 PM#53

One concrete data point for the thread. For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine. Half the figures circulating in this community trace back to a secondary summary that dropped a qualifier.

Last edited: Mar 14, 2024 at 4:53 PM
40 15MarkLI_maint, Dr.PeteFamMed, claudia_zurich and 37 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Mar 15, 2024 at 12:16 AM#54

One thing that is still open after Dr.NutriCornell’s answer:

How would you tell the difference between that and the alternative explanation?

39 14fiona_VT, denise_HTX, raj_cambridge and 36 others
Reply Quote Save Share Report
Dr.RenalNash
VIP Member
1,234
7,890
Mar 2024
Nashville, TN
Mar 15, 2024 at 9:39 AM#55
VendorMark said:
For anyone reading later: the numbers in this thread are worth checking against a primary source before you act on them, including mine.

I read this differently from VendorMark, on substance rather than tone. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

38 13maria_elpaso, anders_CPH, Dr.NutriCornell and 35 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register